Cresco Labs (CRLBF) Receivables - Other (2019 - 2022)

Cresco Labs' (CRLBF) quarterly Receivables - Other came in at $1.0 million in Q1 2022, up 42.86% on a QoQ basis from $700000.0 in Q4 2019.

Cresco Labs (CRLBF) Receivables - Other (2019 - 2022) Analysis & Trends

Cresco Labs (CRLBF) has 2 years of Receivables - Other data on file, last reported at $1.0 million in Q1 2022.

Quarterly Receivables - Other changed N/A year-over-year to $1.0 million in Q1 2022, while the trailing twelve-month figure through Dec 2019 was $700000.0 (changed N/A YoY) and the FY2022 annual result came in at $300000.0, changed N/A from the prior year.
Receivables - Other improved to $1.0 million in Q1 2022, from $700000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $1.0 million in Q1 2022 to a low of $700000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Cresco Labs	295.09 Mn	230.98 Mn	86.95 Mn

Download Data